Today is Global ALS Awareness Day. At iXCells Biotechnologies, we stand with the ALS community, dedicated to advancing research and innovation for those impacted by this challenging disease. We believe in including the voices of those living with ALS/MND in the conversation about research and treatment. On this day, we join The International Alliance of ALS/MND Associations in recognizing the strength and resilience of those living with ALS/MND and their caregivers. Our commitment to accelerating scientific support and creating awareness is unwavering. Join us in our efforts to drive scientific progress and support the ALS community. #neuroscience #diseasemodeling #ALS #ALSMND #GlobalALSAwarenessDay #motorneurons
iXCells Biotechnologies’ Post
More Relevant Posts
-
🔍 Reflecting on a transformative experience! Two weeks ago, Vanessa dos Reis Ferreira, PhD MBA represented Humanized Solutions on the Brain Organoid Panel hosted by Helios Neopharma and ProductLife Group. During this event, Vanessa shed light on the critical role of Patient and Public Involvement and Engagement (PPIE) and the significance of co-creation in fostering patient acceptance for brain organoids. 🧠 The discussions underscored how systematic approaches—tailored to patients and their families—can bridge the gap between groundbreaking research and real-world application. Thank you once again to Yousra Laouarem and Gabrièle Breda for the opportunity to contribute to this important dialogue. 🌍 At Humanized Solutions, we’re committed to ethical, responsible innovation. Reach out to us to explore how we can support your PPIE needs and make a lasting impact: https://bit.ly/3Naf781 #PatientEngagement #BrainOrganoids #HealthcareInnovation #EthicsInScience #RegulatoryScience #PPIE #HumanizedSolutions #Neuroscience
To view or add a comment, sign in
-
-
AnzuBridge’s media capture and review technology has the potential to greatly improve Parkinson's disease clinical trials. By offering accurate motor function assessments and real-time analysis, it helps simplify the process, reducing mistakes and speeding up trial completion. For researchers, this technology is a major improvement, helping to increase data accuracy and move research along faster. #ParkinsonsResearch #ClinicalTrials #InnovationInHealthcare #DataAccuracy #AnzuBridge #HealthcareInnovation #ResearchBreakthrough #FasterTrials #TechForGood
🚀 Advancing Parkinson’s Disease Research with AnzuBridge 🚀 We’re excited to share our latest video showcasing the transformative potential of AnzuBridge’s media capture and review technology in Parkinson’s disease clinical trials. With precise motor function assessments and real-time analysis, this technology streamlines the process, reducing errors and accelerating trial timelines. For the scientific community, this is a game-changer in improving data accuracy and expediting research. 🧬 Watch the video to learn more! 🔬 Book a FREE demo and see the impact firsthand. #ParkinsonsResearch #ClinicalTrials #AnzuBridge #Neuroscience #ScientificInnovation #DataAccuracy
To view or add a comment, sign in
-
Complex #CNS challenges? We’ve got you covered. Discover CenExel, a leading #neuroscience clinical research site network with the expertise and track record to help you get more value from your asset. Learn how now: https://lnkd.in/etsZeuG #ClinicalTrials #PatientRecruitment #Innovation #CenExel
To view or add a comment, sign in
-
-
🚀 Advancing Parkinson’s Disease Research with AnzuBridge 🚀 We’re excited to share our latest video showcasing the transformative potential of AnzuBridge’s media capture and review technology in Parkinson’s disease clinical trials. With precise motor function assessments and real-time analysis, this technology streamlines the process, reducing errors and accelerating trial timelines. For the scientific community, this is a game-changer in improving data accuracy and expediting research. 🧬 Watch the video to learn more! 🔬 Book a FREE demo and see the impact firsthand. #ParkinsonsResearch #ClinicalTrials #AnzuBridge #Neuroscience #ScientificInnovation #DataAccuracy
To view or add a comment, sign in
-
❓Did you know that HODA and NAF share an External Advisory Board Member? It’s true! Dr. Vikram Shakkottai MD PhD serves on HODA’s External Scientific Advisory Board and concurrently serves as the Chairman of NAF’s Medical & Research Advisory Board. Dr. Shakkottai has written papers on both Ataxia and HOD. He will also be the guest speaker of NAF and HODA’s upcoming webinar, “All About Hypertrophic Olivary Degeneration”. 📅When? August 6, 2024 ⌚Time? 8 AM PST/ 9 AM MST / 10 AM CST/ 11AM EST 🔗How Can I Register?: Link in Bio! 🎯During this webinar, an expert (Dr. Shakkottai MD PhD) will discuss Hypertrophic Olivary Degeneration, including the typical diagnostic journey for those affected, what to expect for clinical care, and an overview of current research. This information may also be helpful for individuals with MSA, SCA1, SCA2 and SCA7 who have olivary degeneration. ✔️Register today! We will save you a seat!! #HypertrophicOlivaryDegeneration #HOD #HODHeroes #HODAwareness #MakingHODHistory #NeuroScience #Webinar
To view or add a comment, sign in
-
Big in vision, big in scale and properly big in Quality - Project Mosaic is going to make a big impact to the future of ALS drug discovery. Watch this space. #als #projectmosaic
CEO of Axol Bioscience, enabling “Better Human Disease Models” with iPSC technology in neurodegenerative, eye, cardiac, pain and skin disease
“Project MOSAIC” Truly humbled by the scientific intellect, collaboration, commitment, sense of community and pragmatic problem solving on display today the “Project Mosaic” summit in Washington DC. Special thanks to Bernie Zipprich and the Project Mosaic team for their visionary thought leadership to build better disease models that accelerate and improve drug development and ultimately patients lives with ALS. Axol Bioscience is honoured to have been invited and asked to contribute to this summit. Looking forward to the next step of the journey. Big THANKS Liam #projectmosaic #ALS #motorneurons #neurodegenerativedisease #neuroscience #CNS #ipscs #stemcells #drugdiscovery #patientstratification #collaboration #research #neurodegeneration #nervoussystem #biotech
To view or add a comment, sign in
-
Meet Dr. Fanny Elahi, MD, PhD, a dedicated neurologist-neuroscientist at the Icahn School of Medicine at Mount Sinai, and learn why she joined the Target ALS IRC (Independent Review Committee). At Target ALS, fairness and transparency are at the core of our review process. The Independent Review Committee (IRC), composed of leading experts from academia and industry, makes all funding decisions independently. This ensures that every research application is evaluated fairly, free from any organizational bias or conflicts of interest. No IRC member can apply for or receive Target ALS funding for their own work, and there are no preset limits on the number of grants awarded each cycle, allowing the best research to receive support. Dr. Elahi’s commitment and expertise highlight the collaborative efforts at Target ALS to accelerate research and bring innovative treatments to patients. Her work exemplifies the dedication and interdisciplinary approach necessary to tackle ALS. #ALSResearch #TargetALS #ScientificInnovation #Neuroscience #ResearchCollaboration #EndALS #FairFunding #TransparentReview
To view or add a comment, sign in
-
-
When discussing the application of TMS in a Phase 1 clinical trial with clients, the subject of fixed intensity or threshold tracking TMS protocols inevitably comes up. Our colleague Dr Róisín Mc Mackin and the team at Brainbox Ltd are hosting a webinar in the New Year giving an overview of the techniques with pros and cons of each. #neuroscience #research
To view or add a comment, sign in
-
IMRA Stories from the Field: 2019 Recipient Benjamin Steinberg, MD, PhD, FRCPC With a village of mentors and collaborators behind him and the support of The Scientist Track Investigator program at The Hospital for Sick Children, Benjamin Steinberg, MD, PhD, FRCPC was awarded the 2019 IARS Mentored Research Award for his research, “The Role of Pyroptosis in Neuropathic Pain.” The award helped to build a robust and successful research career in basic science for Dr. Steinberg, specifically focused on the science that most intrigued him - cellular and molecular mechanisms of pain. His initial science sought to implicate some of the key molecules and pathways, specifically a molecule called gasdermin D, and delineate how those pathways feed into the inflammatory burden of pain. However, along the way, they discovered something surprising, a male-female difference or a sexual dimorphism for this immune modulator. Today, that initial discovery has grown wings, creating several big questions leading to intriguing scientific outcomes. Dr. Steinberg and his team continue to work diligently to corroborate their initial findings and then phenotype them. The path from biomedical research to bedside is a long journey, but they hope to get there! #IARSAwards #IMRAStories #AnesthesiaResearch #ResearchAward #PainResearch #BiomedicalScience #ScientificDiscovery Read his interview: https://ow.ly/EtFQ50UuAkj
To view or add a comment, sign in
-
-
MediBrite – High data quality for reliable and save clinical measurements Achieving high and reliable data quality is crucial in clinical research. For this reason, the MediBrite comes with superior features - such as multi-power gain control, ambient light protection, or short separation channels - which do not affect its ease of use. This allows clinicians to record highest quality data within a few minutes, achieving minimum setup time. See how the MediBrite can give you reliable clinical measurements here 🔗 https://lnkd.in/g9MN4-2J #fnirs #clinicalresearch #neuroscience
To view or add a comment, sign in
-